Home | Register | Login | Inquiries | Alerts | Sitemap |  


Advanced Search
JKM > Volume 44(3); 2023 > Article
Lee, Park, Park, Ko, and Cho: A Case Report of Craniosacral Therapy and Acupuncture for Chronic Migraine

Abstract

Objectives

This case report aims to describe the effects of craniosacral therapy and acupuncture in a patient with chronic migraine.

Methods

A 33-year-old man with chronic migraine was treated with 20 sessions of craniosacral therapy and acupuncture for 8 weeks. The number of migraine and headache days were monitored every month. The pain intensity of headache was measured on the visual analog scale (VAS). Korean Headache Impact Test-6 (HIT-6) and Migraine Specific Quality of Life (MSQoL) were also used.

Results

The number of headache days per month reduced from 28 to 7 after 8 weeks of treatment and to 3 after 3 months of treatment. The pain intensity of headache based on VAS reduced from 7.5 to 3 after 8 weeks and further to < 1 after 3 months of treatment. Furthermore, the patient’s HIT-6 and MSQoL scores improved during the treatment period, which was maintained or further improved at the 3 month follow-up. No side effects were observed during or after the treatment.

Conclusion

This case indicates that craniosacral therapy and acupuncture could be effective treatments for chronic migraine. Further studies are required to validate the efficacy of craniosacral therapy for chronic migraine.

Fig. 1
Craniosacral therapy
jkm-44-3-140f1.gif
Fig. 2
Changes in the number of migraine days and headache days per month
jkm-44-3-140f2.gif
Fig. 3
Changes in pain intensity of headache measured on visual analog scale (VAS)
jkm-44-3-140f3.gif
Fig. 4
Changes in Korean headache impact Test-6 (HIT-6) Journal of Korean Medicine 2023;44(3)
jkm-44-3-140f4.gif
Fig. 5
Changes in migraine specific quality of life (MSQoL)
jkm-44-3-140f5.gif

참고문헌

1. Arnold M.2018. Headache classification committee of the International Headache Society (IHS): The international classification of headache disorders. 3rd edition. Cephalalgia. 38:1. p. 1–211. 10.11770333102417738202


2. An H.K., Do J.K., Park J.Y., Han C.H., Lee D.K.2007; Comparisons of life quality between chronic and episodic migraine patients. Journal of the Korean Neurological Association. 25:3. 293–297.


3. Hovaguimian A., Roth J.2022; Management of chronic migraine. British medical journal. 379:e06767010.1136/bmj-2021-067670
crossref pmid

4. Kwak M.J., Han Y.H., Geum J.H., Park S.H., Woo H.J., Ha W.B., Lee J.H.2022; Trends in domestic and international clinical research of craniosacral therapy. Scoping Review Journal of Korean Medicine Rehabilitation. 32:3. 13–27. 10.18325/jkmr.2022.32.3.13


5. Arnadottir T.S., Sigurdardottir A.K.2013; Is craniosacral therapy effective for migraine? Tested with HIT-6 Questionnaire. 19:1. 11–14. 10.1016/j.ctcp.2012.09.003


6. Haller H., Lauche R., Sundberg T., Dobos G., Cramer H.2020; Craniosacral therapy for chronic pain: a systematic review and meta-analysis of randomized controlled trials. BMC Musculoskeletal Disorders. 21:1. 110.1186/s12891-019-3017-y1471-2474.


7. Upledger J.E., Vrendevoogd J.D.1983. Craniosacral therapy. 3rd ed. Seattle: Eastland Press.


8. Blumenfeld A.M., Kaur G., Mahajan A., Shukla H., Sommer K., Tung A., Knievel K.L.2022; Effectiveness and safety of chronic migraine preventive treatments: A Systematic Literature Review. Pain and Therapy. 12:1. 251–274. 10.1007/s40122-022-00452-3
pmid pmc

9. Jensen M.P., Chen C., Brugger A.M.2003; Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. Journal of Pain. 4:7. 407–414. 10.1016/s1526-5900(03)00716-8
crossref pmid

10. Kosinski M., Bayliss M.S., Bjorner J.B., Ware J.E., Garber W.H., Batenhorst A., Cady R., Dahlöf C.G.H., Dowson A., Tepper S.2003; A six-item short-form survey for measuring headache impact: the HIT-6. Quality of life research. 12:8. 963–974. 10.1023/A:1026119331193
pmid

11. Chu M.K., Im H.J., Ju Y.S., Yu K.H., Ma H.I., Kim Y.J., Kim J.Y., Lee B.C.2009; Validity and reliability assessment of Korean headache impact test-6 (HIT-6). Journal of the Korean Neurological Association. 27:1. 1–6.


12. Lipton R.B., Stewart W.F., Sawyer J., Edmeads J.G.2001; Clinical utility of an instrument assessing migraine disability:the Migraine Disability Assessment(MIDAS) questionnaire. Headache. 41:9. 854–861.
crossref pmid

13. Khara M.S., Marianne S.R., Werner J.B., Suzanne N.C., Rose G., Gordon F.M., Arnoldas G.E., Marek J.G.2010; HIT-6 and MIDAS as measures of headache disability in a headache referral population. Headache. 50:3. 383–395. 10.1111/j.1526-4610.2009
crossref pmid

14. Wagner T.H., Patrick D.L., Galer B.S., Berzon R.A.1996; A new instrument to assess the long-term quality of life effects from migraine: development and psychometric testing of the MSQOL. Headache. 36:8. 484–492. 10.1046/j.1526-4610.1996.3608484.x
crossref pmid

15. Moon H.S., Chung C.S., Lee H.S., Park H.S., Kim S.W., Woo H.W.2003; The reliability and validity of the migraine-specific quality of life questionnaire for Korean migraine suffers. Journal of the Korean Neurological Association. 21:2. 146–155.


16. Moon H.S.2018; Comprehensive review and update on chronic migraine. Journal of Korean American Medical Association. 61:5. 314–322. 10.5124/jkma.2018.61.5.314


17. Ishii R., Schwedt T.J., Dumkrieger G., Lalvani N., Craven A., Goadsby P.J., Lipton R.B., Olesen J., Silberstein S.D., Burish M.J., Dodick D.W.2021; Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency. Headache. 61:7. 992–1003. 10.1111/head.14154
pmid

18. Sauro K.M., Rose M.S., Becker W.J., Christie S.N., Giammarco R., Mackie G.F., Eloff A.G., Gawel M.J.2010; HIT-6 and MIDAS as measures of headache disability in a headache referral population. Headache. 50:3. 383–395. 10.1111/j.1526-4610.2009.01544.x
crossref pmid

19. Zhang N., Houle T., Hindiyeh N., Aurora S.K.2020; Systematic review: acupuncture vs standard pharmacological therapy for migraine prevention. Headache. 60:2. 309–317. 10.1111/head.13723
pmid

20. Lee S.J., Lee S.H., Heo I., Hwang E.H., Lim H.H., Song Y.K.2020; Chuna craniosacral therapy for headache: a systematic review and meta analysis. The Journal of Korea CHUNA Manual Medicine for Spine & Nerves. 15:1. 35–48. 10.30581/jkcmm.2020.15.1.35
crossref

Editorial office contact information
3F, #26-27 Gayang-dong, Gangseo-gu Seoul, 157-200 Seoul, Korea
The Society of Korean Medicine
Tel : +82-2-2658-3627   Fax : +82-2-2658-3631   E-mail : skom1953.journal@gmail.com
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Developed in M2PI